Carmignac Gestion’s Doximity DOCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$48.9M Sell
2,355,900
-1,956,097
-45% -$43.3M 0.63% 30
2026
Q1
$100M Buy
4,311,997
+2,418,971
+128% +$75.4M 1.54% 18
2025
Q4
$83.8M Buy
1,893,026
+1,477,798
+356% +$83M 1.13% 23
2025
Q3
$30.4M Hold
415,228
0.45% 41
2025
Q2
$25.5M Buy
415,228
+45,228
+12% +$2.52M 0.39% 42
2025
Q1
$21.5M Buy
370,000
+52,700
+17% +$3.33M 0.35% 42
2024
Q4
$16.9M Buy
317,300
+73,000
+30% +$3.57M 0.27% 51
2024
Q3
$10.6M Buy
244,300
+31,300
+15% +$1.04M 0.18% 61
2024
Q2
$5.96M Buy
+213,000
New +$5.62M 0.1% 72

Other funds holding DOCS

Carmignac Gestion's DOCS Position: Q2 2026 in Review

Carmignac Gestion reduced its Doximity (DOCS) stake by 45% in Q2 2026, selling an estimated $43.3M and leaving 2,355,900 shares worth $48.9M. The position accounts for 0.63% of the portfolio, ranked #30.

Carmignac Gestion first reported a position in DOCS in Q2 2024 and has held it in 9 quarters since. The position peaked at $100M in Q1 2026. 359 funds tracked by Wall St. Rank hold DOCS as of Q2 2026.

  • Carmignac Gestion held 2,355,900 shares of Doximity worth $48.9M as of Q2 2026.
  • Carmignac Gestion sold 1,956,097 Doximity shares in Q2 2026, an estimated $43.3M.
  • Doximity made up 0.63% of Carmignac Gestion's portfolio in Q2 2026, its #30 holding.
  • Carmignac Gestion first reported a position in Doximity in Q2 2024 and has held it in 9 quarters since.
  • Carmignac Gestion's Doximity position peaked at $100M in Q1 2026.
  • 359 funds tracked by Wall St. Rank held Doximity as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.